MVP deficiency, in animal models was associated with increased plasma levels of nonesterified fatty acids, triglycerides, and total cholesterol, and also aggravated obesity and associated IR, hepatic steatosis and atherosclerosis in mice (Ben et al., 2019). The gene discussed is MVP; the disease is fatty liver disease.